72786-101 : Oxbryta 500 mg Oral Tablet, Film Coated
| NDC: | 72786-101 |
| Labeler: | Global Blood Therapeutics Inc. |
| Product Type: | Human Prescription Drug |
| Drug Name: |  Oxbryta |
| Dosage Form: | Oral Tablet, Film Coated |
| Application #: | NDA213137 |
| Rev. Date: |
Appearance:
| Markings: | GBT;500 |
| Shapes: |
Oval |
| Colors: |
 Yellow |
| Size (mm): | 18 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
NDC Package Codes:
- 72786-101-01: 90 TABLET, FILM COATED IN 1 BOTTLE, PLASTIC (72786‑101‑01)
Active Ingredients:
- Voxelotor
Dosage Strength:
- 500 mg
Inactive Ingredients:
- Microcrystalline Cellulose
- Croscarmellose Sodium
- Sodium Lauryl Sulfate
- Silicon Dioxide
- Magnesium Stearate
- Polyethylene Glycol 3350
- Polyvinyl Alcohol, Unspecified
- Talc
- Titanium Dioxide
- Ferric Oxide Yellow /
Pharmaceutical Classes:
- Cytochrome P450 3A4 Inhibitors [MoA]
- Hemoglobin S Polymerization Inhibitor [EPC]
- Hemoglobin S Polymerization Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 72786-102 Oxbryta 300 mg Oral Tablet, Film Coated by Global Blood Therapeutics Inc.
- 72786-111 Oxbryta 300 mg Oral Tablet, for Suspension by Global Blood Therapeutics Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 72785-0011Next: 72786-102 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.